Purchases and Sales Made in Q4 2022 in Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE) during Q4 2022. The information is specifically focused on institutions that hold shares of Ultragenyx Pharmaceutical Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-120K- 95.55% |
$4.06M - $5.57M
|
5.6K
$241K
|
|
|
Feb 06, 2023
Q4 2022
|
Td Asset Management Inc
|
SELL
|
- |
-132K- 50.39% |
$4.46M - $6.13M
|
130K
$5.6M
|
|
|
Feb 14, 2023
Q4 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-182K- 38.61% |
$6.15M - $8.45M
|
290K
$12.5M
|
|
|
Feb 14, 2023
Q4 2022
|
First Light Asset Management, LLC
Edina, MN |
SELL
|
- |
-219K- 48.37% |
$7.4M - $10.2M
|
234K
$10.1M
|
|
|
Feb 13, 2023
Q4 2022
|
Alkeon Capital Management LLC
New York, NY |
SELL
|
- |
-358K- 16.17% |
$12.1M - $16.6M
|
1.85M
$79.8M
|
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-661K- 13.89% |
$22.3M - $30.6M
|
4.1M
$176M
|
|
|
Feb 13, 2023
Q4 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-722K- 18.92% |
$24.3M - $33.4M
|
3.09M
$133M
|
|
|
Feb 13, 2023
Q4 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-843K- 13.95% |
$28.4M - $39.1M
|
5.2M
$224M
|
|
|
Feb 14, 2023
Q4 2022
|
Capital International Investors
Los Angeles, CA |
SELL
|
- |
-2.1M- 61.82% |
$70.7M - $97.1M
|
1.29M
$55.7M
|
|
|
Feb 14, 2023
Q4 2022
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-2.2M- 84.56% |
$74.3M - $102M
|
403K
$17.3M
|